Top

Published in:

01-06-2012 | Maternal-Fetal Medicine

Chitotriosidase, interleukin-1 beta and tumor necrosis factor alpha levels in mild preeclampsia

Authors: Ibrahim Alanbay, Hakan Coksuer, Cihangir Mutlu Ercan, Yusuf Ustun, Gursoy Pala, Kazim Emre Karasahin, Ozlem Ozturk, Ismail Kurt, Iskender Baser

Published in: Archives of Gynecology and Obstetrics | Issue 6/2012

Abstract

Objective

Chitotriosidase (ChT) is an activated macrophage marker. Tumor necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1β) are mainly produced macrophages. The aim of the present study was to evaluate the relationship between serum ChT activity, levels of TNF-α and IL-1β in patients with mild preeclampsia and normal pregnancy.

Methods

An overall 64 cases, 32 healthy pregnant control women (control group) and 32 women with mild preeclamptic patients (study group), were enrolled in this study. At the beginning of the study, all study participants were matched for age and gestational age. Serum ChT activity was measured by fluorometer; TNF-α and IL-1β levels were measured by enzyme-linked immunosorbent assay.

Results

The mean age, gestational week, parity and gravida were similar in the two groups (p > 0.05). Serum ChT activity was significantly higher in the preeclampsia group compared to the control group (p < 0.05). Levels of TNF-α and IL-1β in patients with mild preeclampsia were similar compared to the control group (p > 0.05). In the PE group, serum ChT activity was not correlated with TNF-α and IL-1β.

Conclusion

Mild preeclampsia is found associated with higher ChT activity. This result suggests that activated macrophages play a role in the pathogenesis of preeclampsia. This suggestion needs to be confirmed in future studies with larger populations.

Sibai BM (2003) Diagnosis and management of gestational hypertension-preeclampsia. Obstet Gynecol 102:181–192PubMedCrossRef

Sibai BM (2008) Hypertensive disorders of pregnancy: the United States perspective. Curr Opin Obstet Gynecol 20:102–106PubMedCrossRef

Sibai BM, Dekker G, Kupferminc M (2005) Preeclampsia. Lancet 365:785–799PubMed

Nagamatsu Takeshi, Schust DannyJ (2010) The immunomodulatory roles of macrophages at the maternal–fetal interface. Reprod Sci 17:209–218PubMedCrossRef

Smith SD, Dunk CE, Aplin JD, Harris LK, Jones RL (2009) Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am J Pathol 174(5):1959–1971PubMedCrossRef

Renaud SJ, Postovit LM, Macdonald-Good fellow SK, McDonald GT, Caldwell JD, Graham CH (2005) Activated macrophages inhibit human cytotrophoblast invasiveness in vitro. Biol Reprod 73:237–243PubMedCrossRef

Reister F, Frank HG, Heyl W, Kosanke G, Huppertz B, Schroder W, Kaufmann P, Rath W (1999) The distribution of macrophages in spiral arteries of the placental bed in preeclampsia differs from that in healthy patients. Placenta 20:229–233PubMedCrossRef

Redline RW (2001) Macrophages in the basal plate of preeclamptic placentae. Placenta 22:229–233CrossRef

Haider S, Knöfler M (2009) Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta 30:111–123PubMedCrossRef

10.

Lockwood CJ, Oner C, Uz YH, Kayisli UA, Huang SJ, Buckwalder LF et al (2008) Matrix mettaloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells. Biol Reprod 78:1064–1072PubMedCrossRef

11.

Meisser A, Chardonnens D, Campana A, Bischof P (1999) Effects of tumor necrosis factor-alpha, interleukin1-alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases. Mol Hum Reprod 5:252–260PubMedCrossRef

12.

Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W, Huppertz B (2001) Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 81:1143–1152PubMed

13.

Hollak CE, van Weely S, van Oers MH, Aerts JM (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93:1288PubMedCrossRef

14.

Malaguarnera L (2006) Chitotriosidase: the yin and yang. Cell Mol Life Sci 63:3018–3029PubMedCrossRef

15.

National High Blood Pressure Education Program Working Group (2000) Report on high blood pressure in pregnancy. National Institutes of Health Publication No. 00–3029. National Institutes of Health, Washington

16.

Rusterholz C, Hahn S, Holzgreve W (2007) Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol 29:151–162PubMedCrossRef

17.

Wegmann TG, Lin H, Guilbert L, Mosmann TR (1993) Bidirectional cytokine interactions in the maternal–fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 14:353–356

18.

Redman CW, Sargent IL (2003) Pre-eclampsia, the placenta and the maternal systemic inflammatory response—a review. Placenta 24:2I–27CrossRef

19.

Straszewski S, Kamsteeg M (2002) THe role of the Fas/Fas ligand system in female reproductive organs: survival and apoptosis. Biochem Pharmacol 64:1305–1315PubMedCrossRef

20.

Katabuchi H, Yih S, Ohba T et al (2003) Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells. Med Electron Microsc 36(4):253–262PubMedCrossRef

21.

Crocker IP, Cooper S, Ong SC, Baker PN (2003) Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 162:637–643PubMedCrossRef

22.

Knofler M, Mosl B, Bauer S, Griesinger G, Husslein P (2000) TNF-alpha/TNFRI in primary and immortalized first trimester cytotrophoblasts. Placenta 21:525–553PubMedCrossRef

23.

Madazli R, Kucur M, Gezer A, Isman F, Bulut B (2008) Chitotriosidase and YKL-40 in normal and pre-eclamptic pregnancies. Int J Gynaecol Obstet 100:239–243PubMedCrossRef

24.

Cackovic M, Buhimschi CS, Zhao G, Funai EF, Norwitz ER, Kuczynski E, Lockwood CJ, Buhimschi IA (2008) Fractional excretion of tumor necrosis factor-alpha in women with severe preeclampsia. Obstet Gynecol 112:93–100PubMedCrossRef

25.

Knofler M, Mosl B, Bauer S, Griesinger G, Husslein P (2000) TNF-alpha/TNFR1in primary and immortalized first trimester cytotrophoblasts. Placenta 21:525–535PubMedCrossRef

26.

Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin JD, Knofler M (2004) Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab 89:812–822PubMedCrossRef

27.

Lockwood CJ, Matta P, Krikun G, Koopman LA, Masch R, Toti P, Arcuri F et al (2006) Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia. Am J Pathol 168:445–452PubMedCrossRef

28.

Huang SJ, Schatz F, Masch R, Rahman M, Buchwalder L, Niven-Fairchild T et al (2006) Regulation of chemokine production in response to pro-inflammatory cytokines in first trimester decidual cells. J Reprod Immunol 72:60–73PubMedCrossRef

29.

Renaud SJ, Macdonald-Goodfellow SK, Graham CH (2007) Coordinated regulation of human trophoblast invasiveness by macrophages and interleukin 10. Biol Reprod 76:448–454PubMedCrossRef

30.

Jonsson Y, Ruber M, Matthiesen L, Berg G, Nieminen K, Sharma S, Ernerudh J, Ekerfelt C (2006) Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 70:83–91PubMedCrossRef

31.

Dong M, He J, Wang Z, Xie X, Wang H (2005) Placental imbalance of Th1–and Th2 type cytokines in preeclampsia. Acta Obstet Gynecol Scand 84:788–793PubMed

32.

Bernardi F, Guolo F, Bortolin T, Petronilho F, Dal-Pizzol F (2008) Oxidative stress and inflammatory markers in normal pregnancy and preeclampsia. J Obstet Gynaecol Res 34(6):948–995PubMed

33.

Luppi P, Deloia JA (2006) Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 118:268–275PubMedCrossRef

34.

Montagnana M, Lippi G, Albiero A, Salvagno GL, Tranchi M, Guidi GC (2008) Serum pro-inflamatory cytokines in physiological and pre-eclamptic pregnancies. Gynecol Endocrinol 24:113–116PubMedCrossRef

35.

Serin IS, Ozcelik B, Basbug M, Kilic H, Okur D, Erez R (2002) Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 100:143–145PubMedCrossRef

36.

Chaouat G (2007) The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol 29:95–113PubMedCrossRef

37.

Visser N, van Rijn BB, Rijkers GT, Franx A, Bruinse HW (2007) Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv 62:191–2011PubMedCrossRef

38.

Peracoli JC, Rudge MV, Peracoli MT (2007) Tumor necrosis factor-alpha in gestation and puerperium of women with gestational hypertension and preeclampsia. Am J Reprod Immunol 57:177–185PubMedCrossRef

39.

Di Rosa M, Musumeci M, Scuto A, Musumeci S, Malaguarnera L (2005) Effect of interferon-gamma, interleukin 10, lipopolysaccharide and tumor necrosis factor-alpha on chitotriosidase synthesis in human macrophages. Clin Chem Lab Med 43:499–502PubMedCrossRef

Title: Chitotriosidase, interleukin-1 beta and tumor necrosis factor alpha levels in mild preeclampsia
Authors: Ibrahim Alanbay
Hakan Coksuer
Cihangir Mutlu Ercan
Yusuf Ustun
Gursoy Pala
Kazim Emre Karasahin
Ozlem Ozturk
Ismail Kurt
Iskender Baser
Publication date: 01-06-2012
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 6/2012
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-011-2157-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Chitotriosidase, interleukin-1 beta and tumor necrosis factor alpha levels in mild preeclampsia

Abstract

Objective

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2012

Measures for peripartum hysterectomy for placenta previa accreta: avoiding uterotonic agents and “double distal edge pickup” mass ligation

Analysis of the effectiveness of visual inspection with acetic acid/Lugol’s iodine in one-time and annual follow-up screening in rural China

Type I collagen and matrix metalloproteinase 1, 3 and 9 gene polymorphisms in the predisposition to pelvic organ prolapse

Outcomes and toxicities for the treatment of stage IVB cervical cancer

Women’s well-being after Manchester procedure for pelvic reconstruction with uterine preservation: a follow-up study